| Jung Sook Lee, MD | |
|
1786c Columbia Ave, Columbia, PA 17512-9508 | |
| (717) 684-3663 | |
| (717) 684-9030 |
| Full Name | Jung Sook Lee |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 1786c Columbia Ave, Columbia, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497774186 | NPI | - | NPPES |
| 000654210 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD037840L (Pennsylvania) | Primary |
| Entity Name | Washington Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316917669 PECOS PAC ID: 6103719562 Enrollment ID: O20040209000011 |
News Archive
Novartis announced today new results for Cosentyx® (secukinumab) showing no further progression in joint damage in 84% of patients with psoriatic arthritis (PsA). In addition, Cosentyx maintained a treatment response in joint and skin disease, physical function and quality of life in patients over two years of treatment. These results from the extension phase of the FUTURE 1 study were presented at the 2015 Annual Meeting of the American College of Rheumatology (ACR) in San Francisco, United States.
Glowpoint, Inc., a provider of cloud-based managed services for telepresence, video conferencing and collaboration, today announced that Guardian 24/7, a health care provider for high-profile executives, has selected Glowpoint's video managed services for providing remote diagnosis and patient collaboration using high-quality video conferencing.
A research paper recently uploaded to the preprint server bioRxiv by Dominguez-Vega et al. (23rd Feb, 2021) describes an in-depth structural analysis of the RBD of the spike protein expressed in mammalian Chinese hamster ovary (CHO) cells and human embryonic kidney (HEK293) cells, providing a new understanding of protein structure and function.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
› Verified 5 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
Novartis announced today new results for Cosentyx® (secukinumab) showing no further progression in joint damage in 84% of patients with psoriatic arthritis (PsA). In addition, Cosentyx maintained a treatment response in joint and skin disease, physical function and quality of life in patients over two years of treatment. These results from the extension phase of the FUTURE 1 study were presented at the 2015 Annual Meeting of the American College of Rheumatology (ACR) in San Francisco, United States.
Glowpoint, Inc., a provider of cloud-based managed services for telepresence, video conferencing and collaboration, today announced that Guardian 24/7, a health care provider for high-profile executives, has selected Glowpoint's video managed services for providing remote diagnosis and patient collaboration using high-quality video conferencing.
A research paper recently uploaded to the preprint server bioRxiv by Dominguez-Vega et al. (23rd Feb, 2021) describes an in-depth structural analysis of the RBD of the spike protein expressed in mammalian Chinese hamster ovary (CHO) cells and human embryonic kidney (HEK293) cells, providing a new understanding of protein structure and function.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
› Verified 5 days ago
| Entity Name | Pinnacle Health Regional Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013441690 PECOS PAC ID: 7416228358 Enrollment ID: O20170810001731 |
News Archive
Novartis announced today new results for Cosentyx® (secukinumab) showing no further progression in joint damage in 84% of patients with psoriatic arthritis (PsA). In addition, Cosentyx maintained a treatment response in joint and skin disease, physical function and quality of life in patients over two years of treatment. These results from the extension phase of the FUTURE 1 study were presented at the 2015 Annual Meeting of the American College of Rheumatology (ACR) in San Francisco, United States.
Glowpoint, Inc., a provider of cloud-based managed services for telepresence, video conferencing and collaboration, today announced that Guardian 24/7, a health care provider for high-profile executives, has selected Glowpoint's video managed services for providing remote diagnosis and patient collaboration using high-quality video conferencing.
A research paper recently uploaded to the preprint server bioRxiv by Dominguez-Vega et al. (23rd Feb, 2021) describes an in-depth structural analysis of the RBD of the spike protein expressed in mammalian Chinese hamster ovary (CHO) cells and human embryonic kidney (HEK293) cells, providing a new understanding of protein structure and function.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jung Sook Lee, MD 409 S 2nd St Ste 2f, Harrisburg, PA 17104-1612 Ph: () - | Jung Sook Lee, MD 1786c Columbia Ave, Columbia, PA 17512-9508 Ph: (717) 684-3663 |
News Archive
Novartis announced today new results for Cosentyx® (secukinumab) showing no further progression in joint damage in 84% of patients with psoriatic arthritis (PsA). In addition, Cosentyx maintained a treatment response in joint and skin disease, physical function and quality of life in patients over two years of treatment. These results from the extension phase of the FUTURE 1 study were presented at the 2015 Annual Meeting of the American College of Rheumatology (ACR) in San Francisco, United States.
Glowpoint, Inc., a provider of cloud-based managed services for telepresence, video conferencing and collaboration, today announced that Guardian 24/7, a health care provider for high-profile executives, has selected Glowpoint's video managed services for providing remote diagnosis and patient collaboration using high-quality video conferencing.
A research paper recently uploaded to the preprint server bioRxiv by Dominguez-Vega et al. (23rd Feb, 2021) describes an in-depth structural analysis of the RBD of the spike protein expressed in mammalian Chinese hamster ovary (CHO) cells and human embryonic kidney (HEK293) cells, providing a new understanding of protein structure and function.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
› Verified 5 days ago
Diane K Donnelly, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3985 Columbia Ave Ste 8, Columbia, PA 17512 Phone: 717-285-3144 Fax: 717-285-3529 | |
Kelsey Czekai, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 369 Locust Street, First Floor, Columbia, PA 17512 Phone: 717-342-2577 Fax: 717-449-5082 | |
Thomas C Coyne, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 N 7th St, Columbia, PA 17512 Phone: 717-684-9106 Fax: 717-684-1666 | |
Adrienne K Kuhlengel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 N 7th St, Columbia, PA 17512 Phone: 717-684-9106 Fax: 717-684-1666 | |
Dr. Adrian Farris Hazbun, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3985 Columbia Ave Ste 8, Columbia, PA 17512 Phone: 717-285-3144 Fax: 717-295-9098 | |
Dr. Eugene John Romano, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1786c Columbia Ave, Columbia, PA 17512 Phone: 717-684-3663 Fax: 717-684-9030 | |
Brian Young, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 N 7th St, Columbia, PA 17512 Phone: 717-684-9106 |